- Home
- MDGL vs AVTR Comparison
MDGL vs AVTR Comparison
Compare MDGL & AVTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDGL | AVTR |
|---|---|---|
| Founded | 2011 | 1904 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 11.0B |
| IPO Year | 2005 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MDGL | AVTR |
|---|---|---|
| Price | $426.48 | $15.59 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 19 | 15 |
| Target Price | ★ $688.94 | $17.35 |
| AVG Volume (30 Days) | 528.6K | ★ 10.4M |
| Earning Date | 11-03-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.42 |
| Revenue | $180,133,000.00 | ★ $6,552,200,000.00 |
| Revenue This Year | $65.40 | $1.80 |
| Revenue Next Year | $37.72 | $2.84 |
| P/E Ratio | ★ N/A | $37.71 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $353.54 | $7.27 |
| 52 Week High | $615.00 | $17.45 |
Technical Indicators
Market Signals| Indicator | MDGL | AVTR |
|---|---|---|
| Relative Strength Index (RSI) | 42.65 | 46.84 |
| Support Level | $416.21 | $14.57 |
| Resistance Level | $553.95 | $16.21 |
| Average True Range (ATR) | 24.47 | 0.57 |
| MACD | 3.66 | -0.13 |
| Stochastic Oscillator | 57.55 | 24.89 |
Price Performance
Historical ComparisonAbout MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
About AVTR Avantor Inc.
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.